oxybutynin has been researched along with Urinary Incontinence, Stress in 19 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Urinary Incontinence, Stress: Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The most common adverse event for OXY-TDS was localized application site pruritus (14% versus 4% placebo) accompanied by a low incidence of systemic side effects (eg, dry mouth 4." | 2.71 | Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. ( Davila, GW; Dmochowski, RR; Gittelman, MC; Sand, PK; Sanders, SW; Zinner, NR, 2003) |
| " Safety monitoring included adverse events and skin tolerability of the transdermal system." | 2.70 | A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. ( Daugherty, CA; Davila, GW; Sanders, SW, 2001) |
| "Oxybutynin chloride was not well tolerated while bladder-sphincter-biofeedback was well accepted." | 2.69 | Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin. ( Wang, AC, 2000) |
| "One hundred twenty-one women, 55 with urinary stress incontinence (USI), 20 with urge incontinence (UI) and 46 suffering from both types of incontinence, underwent rehabilitative therapy." | 2.67 | [Rehabilitation therapy in the treatment of female urinary incontinence. Our experience with 121 patients]. ( Grasso-Leanza, F; Panella, P; Pennisi, M; Pepe, P, 1994) |
| "7% of patients cited adverse events as the reason for discontinuing." | 2.43 | Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies. ( Anderson, RU; Armstrong, RB; Dmochowski, RR; MacDiarmid, SA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbst, J | 1 |
| Gilbert, JD | 1 |
| Byard, RW | 1 |
| Hader, C | 1 |
| Welz-Barth, A | 1 |
| Keller, T | 1 |
| Dmochowski, RR | 3 |
| Sand, PK | 1 |
| Zinner, NR | 1 |
| Gittelman, MC | 1 |
| Davila, GW | 2 |
| Sanders, SW | 2 |
| Shultz, JM | 1 |
| Rosenberg, MT | 1 |
| MacDiarmid, SA | 1 |
| Anderson, RU | 1 |
| Armstrong, RB | 1 |
| Brubaker, L | 1 |
| Chapple, C | 1 |
| Coyne, KS | 1 |
| Kopp, Z | 1 |
| Vella, M | 1 |
| Robinson, D | 1 |
| Cardozo, L | 1 |
| Cartwright, R | 1 |
| Pennisi, M | 1 |
| Grasso-Leanza, F | 1 |
| Panella, P | 1 |
| Pepe, P | 1 |
| Amarenco, G | 1 |
| Marquis, P | 1 |
| McCarthy, C | 1 |
| Richard, F | 1 |
| Lekan-Rutledge, D | 1 |
| Burgio, KL | 1 |
| Locher, JL | 1 |
| Goode, PS | 1 |
| Wang, AC | 1 |
| Appell, RA | 1 |
| Sand, P | 1 |
| Dmochowski, R | 1 |
| Anderson, R | 1 |
| Zinner, N | 1 |
| Lama, D | 1 |
| Roach, M | 1 |
| Miklos, J | 1 |
| Saltzstein, D | 1 |
| Boone, T | 1 |
| Staskin, DR | 1 |
| Albrecht, D | 1 |
| Daugherty, CA | 1 |
| Blonski, J | 1 |
| van Waalwijk van Doorn, ES | 1 |
| Zwiers, W | 1 |
| Karram, MM | 1 |
| Bhatia, NN | 1 |
| Snustad, DG | 1 |
| Rosenthal, JT | 1 |
6 reviews available for oxybutynin and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Urinary incontinence. Solving a secret problem.
Topics: Activities of Daily Living; Attitude to Health; Behavior Therapy; Exercise Therapy; Humans; Mandelic | 2003 |
Overactive bladder: evaluation and management in primary care.
Topics: Algorithms; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols | 2005 |
Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Delayed-Action Preparations; Female; | 2005 |
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Health Status; Humans; Mandelic Acids; Musc | 2006 |
New developments in the treatment of urinary incontinence.
Topics: Administration, Cutaneous; Adrenergic Uptake Inhibitors; Benzofurans; Drug Therapy, Combination; Dul | 2006 |
Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence?
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Confidence Intervals; Cresols; Dose-Respons | 2001 |
8 trials available for oxybutynin and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Dermatitis, Contact; | 2003 |
[Rehabilitation therapy in the treatment of female urinary incontinence. Our experience with 121 patients].
Topics: Adult; Aged; Biofeedback, Psychology; Combined Modality Therapy; Electric Stimulation Therapy; Femal | 1994 |
[Quality of life of women with stress urinary incontinence with or without pollakiuria].
Topics: Adult; Female; Humans; Mandelic Acids; Middle Aged; Parasympatholytics; Prospective Studies; Quality | 1998 |
Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Behavior Therapy; Biofeedback, Psychology; Exercise Therapy; Female; Humans | 1999 |
Combined behavioral and drug therapy for urge incontinence in older women.
Topics: Aged; Aged, 80 and over; Behavior Therapy; Biofeedback, Psychology; Cross-Over Studies; Double-Blind | 2000 |
Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin.
Topics: Adult; Aged; Biofeedback, Psychology; Cholinergic Antagonists; Exercise Therapy; Female; Humans; Man | 2000 |
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administ | 2001 |
A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Cholinergic Antagonists; Dose-Response | 2001 |
5 other studies available for oxybutynin and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Urinary incontinence, hyperthermia, and sudden death.
Topics: Aged, 80 and over; Cardiomegaly; Cholinergic Antagonists; Death, Sudden; Exercise; Female; Fever; Fo | 2011 |
[Urinary incontinence--treatment].
Topics: Adrenergic Uptake Inhibitors; Behavior Therapy; Benzhydryl Compounds; Benzilates; Biofeedback, Psych | 2003 |
Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence.
Topics: Adult; Female; Humans; Male; Mandelic Acids; Monitoring, Physiologic; Muscle Contraction; Parasympat | 1990 |
Management of coexistent stress and urge urinary incontinence.
Topics: Adult; Aged; Drug Therapy, Combination; Estrogens; Female; Humans; Imipramine; Mandelic Acids; Middl | 1989 |
Urinary incontinence in the elderly.
Topics: Aged; Female; Humans; Imipramine; Mandelic Acids; Muscle, Smooth; Parasympatholytics; Propantheline; | 1985 |